WELFUCO-200 contains Fluconazole 200 mg, a systemic triazole antifungal formulated for the treatment of susceptible fungal infections. A valuable addition to the PCD Pharma Derma & Anti-Fungal portfolio.
Treatment of susceptible fungal infections.
No, it is an antifungal medicine.
Use strictly as prescribed and complete the recommended course. Inform the physician about liver disease, pregnancy, heart-rhythm disorders or other medicines due to potential interactions.
Nausea, abdominal discomfort, diarrhea, headache, dizziness and skin rash may occur. Liver enzyme elevation can occur in some patients.
WELFUCO-200: Fluconazole inhibits fungal ergosterol synthesis, disrupting the fungal cell membrane and inhibiting fungal growth.
